UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Systematic review: quality of trials on the symptomatic effects of the low FODMAP diet for irritable bowel syndrome

Alimentary pharmacology & therapeutics, 2017-06, Vol.45 (12), p.1506-1513

2017

Volltextzugriff (PDF)

Randomised clinical trial: addition of alginate‐antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms

Alimentary pharmacology & therapeutics, 2017-06, Vol.45 (12), p.1524-1533

2017

Volltextzugriff (PDF)

Randomised clinical trial: alginate (Gaviscon Advance) vs. placebo as add‐on therapy in reflux patients with inadequate response to a once daily proton pump inhibitor

Alimentary pharmacology & therapeutics, 2016-04, Vol.43 (8), p.899-909

2016

Volltextzugriff (PDF)

Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study

Gut, 2010-06, Vol.59 (6), p.714-721

2010

Volltextzugriff (PDF)

Short-term stability of subtypes in the irritable bowel syndrome: prospective evaluation using the Rome III classification

Alimentary pharmacology & therapeutics, 2012-02, Vol.35 (3), p.350-359

2012

Volltextzugriff (PDF)

Editorial: refractory GERD—good drug, wrong patients? Authors’ reply

Alimentary pharmacology & therapeutics, 2017-07, Vol.46 (2), p.204-205

2017

Volltextzugriff (PDF)

Letter: add‐on alginate therapy for reflux patients with inadequate response to a once daily proton pump inhibitor – more questions than answers. Authors’ reply

Alimentary pharmacology & therapeutics, 2016-07, Vol.44 (2), p.208-208

2016

Volltextzugriff (PDF)

Editorial: alginates for inadequate response to a proton pump inhibitor in gastro‐oesophageal reflux disease – authors’ reply

Alimentary pharmacology & therapeutics, 2016-05, Vol.43 (10), p.1104-1104

2016

Volltextzugriff (PDF)

Impact of an information video before colonoscopy on patient satisfaction and anxiety - a randomized trial

Endoscopy, 2007-08, Vol.39 (8), p.710-714

2007

Volltextzugriff (PDF)

Letter: bias in clinical trials of the symptomatic effects of the low FODMAP diet for irritable bowel syndrome—getting the facts right. Authors' reply

Alimentary pharmacology & therapeutics, 2017-08, Vol.46 (3), p.386-387

2017

Volltextzugriff (PDF)

Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis - a post hoc analysis of 5796 patients

Alimentary pharmacology & therapeutics, 2012-10, Vol.36 (7), p.635-643

2012

Volltextzugriff (PDF)

Assessment of reflux symptom severity: methodological options and their attributes

Gut, 2004-05, Vol.53 (suppl 4), p.iv28-iv34

Bytzer, P

2004

Volltextzugriff (PDF)

Clinical trial: long‐term use of proton pump inhibitors in primary care patients – a cross sectional analysis of 901 patients

Alimentary pharmacology & therapeutics, 2009-10, Vol.30 (7), p.725-732

2009

Volltextzugriff (PDF)

The epidemiology of irritable bowel syndrome: Symptom development over a 3‐year period in Denmark. A prospective, population‐based cohort study

Neurogastroenterology and motility, 2017-04, Vol.29 (4), p.np-n/a

2017

Volltextzugriff (PDF)

Use of acid‐suppressive therapy before anti‐reflux surgery in 2922 patients: a nationwide register‐based study in Denmark

Alimentary pharmacology & therapeutics, 2015-07, Vol.42 (1), p.84-90

2015

Volltextzugriff (PDF)

Editorial: anti‐secretory therapy prior to anti‐reflux surgery. Does dose matter? Authors’ reply

Alimentary pharmacology & therapeutics, 2015-09, Vol.42 (5), p.627-627

2015

Volltextzugriff (PDF)

Clinical trial: the glucagon‐like peptide‐1 analogue ROSE‐010 for management of acute pain in patients with irritable bowel syndrome: a randomized, placebo‐controlled, double‐blind study

Alimentary pharmacology & therapeutics, 2009-01, Vol.29 (2), p.198-206

2009

Volltextzugriff (PDF)

A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation

Gut, 2005-12, Vol.54 (12), p.1707-1713

2005

Volltextzugriff (PDF)

H2 receptor antagonists and prokinetics in dyspepsia: a critical review

Gut, 2002-05, Vol.50 (suppl 4), p.iv58-iv62

Bytzer, P

2002

Volltextzugriff (PDF)

Irritable bowel syndrome: The burden and unmet needs in Europe

Digestive and liver disease, 2006-10, Vol.38 (10), p.717-723

2006

Volltextzugriff (PDF)

Six‐month trial of on‐demand rabeprazole 10 mg maintains symptom relief in patients with non‐erosive reflux disease

Alimentary pharmacology & therapeutics, 2004-07, Vol.20 (2), p.181-188

2004

Volltextzugriff (PDF)

The Rome II and Rome III criteria identify the same subtype-populations in irritable bowel syndrome: agreement depends on the method used for symptom report

Neurogastroenterology and motility, 2012-07, Vol.24 (7), p.604-e266

2012

Volltextzugriff (PDF)

Appropriateness of colonoscopy in Europe (EPAGE II). Screening for colorectal cancer

Endoscopy, 2009-03, Vol.41 (3), p.200-208

2009

Volltextzugriff (PDF)

Randomised clinical trial: identification of responders to short‐term treatment with esomeprazole for dyspepsia in primary care – a randomised, placebo‐controlled study

Alimentary pharmacology & therapeutics, 2011-01, Vol.33 (1), p.41-49

2011

Volltextzugriff (PDF)

Proton-Pump Inhibitor Therapy Induces Acid-Related Symptoms in Healthy Volunteers After Withdrawal of Therapy

Gastroenterology (New York, N.Y. 1943), 2009-07, Vol.137 (1), p.80-87.e1

2009

Volltextzugriff (PDF)

1 – 25 von 187

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(158)
Mit Volltextzugriff
(124)

Publikationsform

Artikel
(187)

Sprache

Englisch
(161)
Dänisch
(23)
Japanisch
(15)
Deutsch
(3)
Norwegisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(131)
Life Sciences & Biomedicine
(103)
Science & Technology
(103)
Gastroenterology & Hepatology
(86)
Middle Aged
(75)
Biological And Medical Sciences
(74)
Medical Sciences
(74)
Female
(73)
Male
(73)
Adult
(64)
Aged
(49)
Gastroenterology. Liver. Pancreas. Abdomen
(40)
Pharmacology. Drug Treatments
(36)
Digestive System
(30)
Other Diseases. Semiology
(30)
Pharmacology & Pharmacy
(27)
Endoscopy
(26)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(26)
Treatment Outcome
(23)
Anti-Ulcer Agents - Therapeutic Use
(20)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Alimentary Pharmacology & Therapeutics
(34)
Ugeskrift For Læger
(22)
Gastroenterology
(18)
Scandinavian Journal Of Gastroenterology
(18)
The American Journal Of Gastroenterology
(14)
Gut
(13)
Endoscopy
(9)
Bmj
(5)
Bmj. British Medical Journal
(5)
British Medical Journal
(5)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Systematic review: quality of trials on the symptomatic effects of the low FODMAP diet for irritable bowel syndrome

Randomised clinical trial: addition of alginate‐antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms

Randomised clinical trial: alginate (Gaviscon Advance) vs. placebo as add‐on therapy in reflux patients with inadequate response to a once daily proton pump inhibitor

Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study

Short-term stability of subtypes in the irritable bowel syndrome: prospective evaluation using the Rome III classification

Editorial: refractory GERD—good drug, wrong patients? Authors’ reply

Letter: add‐on alginate therapy for reflux patients with inadequate response to a once daily proton pump inhibitor – more questions than answers. Authors’ reply

Editorial: alginates for inadequate response to a proton pump inhibitor in gastro‐oesophageal reflux disease – authors’ reply

Impact of an information video before colonoscopy on patient satisfaction and anxiety - a randomized trial

Letter: bias in clinical trials of the symptomatic effects of the low FODMAP diet for irritable bowel syndrome—getting the facts right. Authors' reply

Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis - a post hoc analysis of 5796 patients

Assessment of reflux symptom severity: methodological options and their attributes

Clinical trial: long‐term use of proton pump inhibitors in primary care patients – a cross sectional analysis of 901 patients

The epidemiology of irritable bowel syndrome: Symptom development over a 3‐year period in Denmark. A prospective, population‐based cohort study

Use of acid‐suppressive therapy before anti‐reflux surgery in 2922 patients: a nationwide register‐based study in Denmark

Editorial: anti‐secretory therapy prior to anti‐reflux surgery. Does dose matter? Authors’ reply

Clinical trial: the glucagon‐like peptide‐1 analogue ROSE‐010 for management of acute pain in patients with irritable bowel syndrome: a randomized, placebo‐controlled, double‐blind study

A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation

H2 receptor antagonists and prokinetics in dyspepsia: a critical review

Irritable bowel syndrome: The burden and unmet needs in Europe

Six‐month trial of on‐demand rabeprazole 10 mg maintains symptom relief in patients with non‐erosive reflux disease

The Rome II and Rome III criteria identify the same subtype-populations in irritable bowel syndrome: agreement depends on the method used for symptom report

Appropriateness of colonoscopy in Europe (EPAGE II). Screening for colorectal cancer

Randomised clinical trial: identification of responders to short‐term treatment with esomeprazole for dyspepsia in primary care – a randomised, placebo‐controlled study

Proton-Pump Inhibitor Therapy Induces Acid-Related Symptoms in Healthy Volunteers After Withdrawal of Therapy

Suchergebnisse filtern